Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 183.95 | 182.77 | 238.76 | 194.22 | 157.89 |
Total Expenses | 174.58 | 166.91 | 175.87 | 170.79 | 141.58 |
Profit Before Tax | 6.65 | 15.17 | 54.19 | 32.54 | 14.94 |
Profit After Tax | 5.68 | 11.45 | 47.22 | 29.35 | 14.06 |
Operating Profit After Depreciation | 13.12 | 18.30 | 64.59 | 26.38 | 19.64 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 87.57 | 85.17 | 58.34 | 56.86 | 57.46 |
Total Non Current Assets | 131.68 | 134.80 | 110.31 | 89.46 | 82.47 |
Total Current Assets | 118.54 | 110.94 | 120.19 | 120.59 | 103.98 |
Total Assets | 250.23 | 245.74 | 230.50 | 210.05 | 186.45 |
Total Shareholder's Fund | 137.13 | 130.92 | 119.87 | 73.90 | 44.77 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash From Operating Activities | 4.72 | 5.72 | 11.47 | -2.30 | -6.88 |
Net Cash Used In Investing Activities | -1.13 | -16.78 | 5.08 | 10.09 | 16.89 |
Net Cash Used In Financing Activities | -2.95 | 9.09 | -19.19 | -5.84 | -14.22 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 11.70 | 14.24 | 39.66 | 29.61 | 24.61 |
Total Expenses | 10.89 | 9.12 | 6.13 | 39.08 | 8.71 |
Profit Before Tax | 0.81 | 4.34 | 3.45 | -9.47 | 15.90 |
Profit After Tax | 2.58 | 4.11 | 2.96 | -9.39 | 15.55 |
Operating Profit After Depreciation | 1.01 | 5.23 | 33.78 | -8.91 | 16.37 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 12.84 | 12.86 | 13 | 13.97 | 14.48 |
Total Non Current Assets | 44.79 | 45.35 | 40.40 | 51.51 | 81.17 |
Total Current Assets | 36.49 | 34.40 | 42.59 | 48.54 | 43.43 |
Total Assets | 81.28 | 79.74 | 82.99 | 100.05 | 124.60 |
Total Shareholder's Fund | 40.29 | 37.85 | 33.70 | 30.79 | 40.25 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash From Operating Activities | -3.82 | 1.52 | -7.79 | -10.42 | -4.53 |
Net Cash Used In Investing Activities | 3.48 | 0.61 | 20.77 | 15.76 | 4.92 |
Net Cash Used In Financing Activities | 0.30 | -3.76 | -16.46 | -0.32 | -0.42 |
Particulars (in ₹ Cr.) | 2024-12 | 2024-09 | 2024-06 | 2024-03 | 2023-12 |
---|---|---|---|---|---|
Total Revenue | 45.97 | 44.70 | 40.70 | 54.35 | 43.11 |
Total Expenses | 46.67 | 42.17 | 40.22 | 49.70 | 40.59 |
Profit Before Tax | 2.93 | 3.10 | 0.85 | 8.29 | 2.02 |
Profit After Tax | 2.23 | 2.62 | 0.35 | 9.02 | 1.33 |
Operating Profit after Depreciation | 5.06 | 5.33 | 2.78 | 9.44 | 4.14 |
Particulars (in ₹ Cr.) | 2024-12 | 2024-09 | 2024-06 | 2024-03 | 2023-12 |
---|---|---|---|---|---|
Total Revenue | 1.17 | - | 1.14 | 0.99 | 0.33 |
Total Expenses | 3.74 | 1.79 | 2.40 | 1.65 | 1.95 |
Profit Before Tax | 8.12 | 4.46 | 0.50 | 2.66 | -0.38 |
Profit After Tax | 8.43 | 4.31 | 0.46 | 4.70 | -0.65 |
Operating Profit after Depreciation | 3.09 | 4.58 | 0.62 | 2.76 | -0.29 |
Company | Price | Market Cap (in Cr) |
---|---|---|
Sun Pharmaceutical Industries Ltd | ₹1,781.35 | ₹4,27,405.53 |
Divis Laboratories Ltd | ₹6,144.35 | ₹1,63,113.19 |
Cipla Ltd | ₹1,508.95 | ₹1,21,868.90 |
Torrent Pharmaceuticals Ltd | ₹3,289.90 | ₹1,11,340.16 |
Mankind Pharma Ltd | ₹2,430.05 | ₹1,00,258.65 |
No data available
On 14 February 2025
06 Feb 2025, 11:55 am
On 12 November 2024
05 Nov 2024, 01:38 pm
On 9 August 2024
03 Aug 2024, 10:31 am
On 29 June 2024
29 May 2024, 03:01 pm
On 24 May 2024
17 May 2024, 02:26 pm
Get started with us today and
start
building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.
Get started with us today and
start
building your wealth journey
*By clicking, I agree to the T&C and Whatsapp updates.
Congratulations,
Your Digital savings bank account opening journey is complete.